679-P: The Novel GIP, GLP-1, and Glucagon Triple Receptor Agonist LY3437943 Exhibits Robust Efficacy in Preclinical Models of Obesity and Diabetes
2006 ◽
Vol 4
(12)
◽
pp. 171-172
2011 ◽
Vol 67
(2)
◽
pp. o71-o76
◽
Keyword(s):
2008 ◽
Vol 155
(4)
◽
pp. 547-557
◽
Keyword(s):
2020 ◽
Vol 10
(2)
◽
pp. 523-542
◽
Keyword(s):
2019 ◽
Vol 176
(20)
◽
pp. 3972-3982
◽
1999 ◽
Vol 26
(6)
◽
pp. 633-640
◽